COMUNICATO STAMPA SPONSORIZZATO – NORDIC GROUP B.V. THROUGH ITS SUBSIDIARY NORDIC PHARMA, INC. (U.S.), TO SHARE PATIENT DATA AND PATIENT EXPERIENCE STUDY FOR LACRIFILL® CANALICULAR GEL, A NOVEL THERAPY FOR DRY EYE, DURING AMERICAN ACADEMY OF OPHTHALMOLOGY (AAO) 2025
16 Ottobre 2025 | immediapress
(Immediapress) – BERWYN, Pa., Oct. 16, 2025 /PRNewswire/ — Nordic Pharma, Inc., a subsidiary of Nordic Group B.V., will be featuring LACRIFILL Canalicular Gel, a novel therapy for dry eye symptoms, at the American Academy of Ophthalmology Annual Meeting in Orlando, FL from October 18-20…